Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2026-02-12 Earnings Release
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Ipsen delivers strong results in 2025, driven by solid execution across all therapeutic areas, and provides 2026 guidance
Earnings Release Classification · 1% confidence The document is a press release from Ipsen titled 'Ipsen delivers strong results in 2025'. It provides a summary of financial performance, including sales growth, core operating income, and earnings per share, as well as forward-looking guidance for 2026. It explicitly states that the full audited financial statements will be available on their website later, confirming this document is the initial announcement of results rather than the full annual report itself. Therefore, it is classified as an Earnings Release. FY 2025
2026-02-12 English
Ipsen - Janvier 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Regulatory Filings Classification · 1% confidence The document is a monthly disclosure of the total number of voting rights and shares composing the share capital, as required by Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF General Regulation. This is a standard regulatory disclosure regarding share capital structure and voting rights, which does not fit into specific categories like 'Major Shareholding Notification' (which tracks individual investors) or 'Share Issue' (which tracks specific corporate actions). Therefore, it falls under the general regulatory filing category.
2026-02-09 French
Ipsen - January 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
Regulatory Filings Classification · 1% confidence The document is a monthly disclosure of the total number of voting rights and shares composing the share capital, as required by Article L.233-8 II of the French Commercial Code. This is a standard regulatory disclosure regarding share capital structure and voting rights, which does not fit into specific categories like 'Share Issue' or 'Major Shareholding Notification' (which tracks individual holders). It is a general regulatory filing required by the AMF.
2026-02-09 English
Ipsen nominates Peter Guenter to its Board of Directors
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new member to the Board of Directors at Ipsen. This falls directly under the category of announcements regarding changes in the company's board of directors or senior management.
2026-01-29 English
Ipsen nomme Peter Guenter au sein de son Conseil d’Administration
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new member, Peter Guenter, to the Board of Directors of Ipsen. It details his professional background, the composition of the board following his appointment, and the procedural ratification process. This falls squarely under the category of board and management changes.
2026-01-29 French
Pierrick Lefranc nommé Vice-Président Exécutif Opérations Techniques et membre du Comité Exécutif
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new Executive Vice President of Technical Operations and a member of the Executive Committee at Ipsen. It details the transition between the incoming executive, Pierrick Lefranc, and the outgoing executive, Aidan Murphy. This falls squarely under the category of board or management changes.
2026-01-27 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.